Megino-Luque, C.; Moiola, C.P.; Molins-Escuder, C.; López-Gil, C.; Gil-Moreno, A.; Matias-Guiu, X.; Colas, E.; Eritja, N.
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer. Cancers 2020, 12, 2751.
https://doi.org/10.3390/cancers12102751
AMA Style
Megino-Luque C, Moiola CP, Molins-Escuder C, López-Gil C, Gil-Moreno A, Matias-Guiu X, Colas E, Eritja N.
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer. Cancers. 2020; 12(10):2751.
https://doi.org/10.3390/cancers12102751
Chicago/Turabian Style
Megino-Luque, Cristina, Cristian Pablo Moiola, Clara Molins-Escuder, Carlos López-Gil, Antonio Gil-Moreno, Xavier Matias-Guiu, Eva Colas, and Núria Eritja.
2020. "Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer" Cancers 12, no. 10: 2751.
https://doi.org/10.3390/cancers12102751
APA Style
Megino-Luque, C., Moiola, C. P., Molins-Escuder, C., López-Gil, C., Gil-Moreno, A., Matias-Guiu, X., Colas, E., & Eritja, N.
(2020). Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer. Cancers, 12(10), 2751.
https://doi.org/10.3390/cancers12102751